OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PAJS50

Pajson Agro India Ltd

Food ProcessingVerified

Pajson Agro India Ltd has a fully diluted share count of 23,809,595 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for comparison against industry benchmarks, as the valuation snapshot does not include key financial ratios such as ROIC, EBITDA margins, or net profit margins. This limits the ability to assess the company's performance relative to its peers in the Food Processing industry. The company's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to evaluate the risk associated with its business segments or regional dependencies. Growth trajectory is also unclear, as the outlook for the current and next fiscal year does not include numeric deltas or directional guidance for revenue or earnings. This lack of forward-looking data hinders the ability to model future performance. Risk factors include the inability to assess liquidity risk, which is a critical concern for any company's financial health. Additionally, the absence of detailed risk assessments and the lack of disclosed dilution sources make it challenging to evaluate the company's exposure to external pressures. Recent events, such as filings or transcripts, are not available in the provided data, which limits the ability to understand the company's strategic direction or operational developments.

30-day price · PAJS+14.50 (+8.8%)
Low$140.10High$218.00Close$179.80As of13 May, 00:00 UTC
Profile
CompanyPajson Agro India Ltd
TickerPAJS.BO
SectorConsumer Non-Cyclicals
BusinessFood & Beverages
Industry groupFood & Beverages
IndustryFood Processing
AI analysis

Business. (unavailable from LLM output)

Classification. (unavailable from LLM output)

Pajson Agro India Ltd has a fully diluted share count of 23,809,595 shares, with no difference between basic and diluted shares outstanding, indicating no dilution from stock options or convertible securities. However, liquidity risk could not be assessed due to the absence of balance-sheet inputs and no going-concern language in source documents. Profitability and return metrics are not available for comparison against industry benchmarks, as the valuation snapshot does not include key financial ratios such as ROIC, EBITDA margins, or net profit margins. This limits the ability to assess the company's performance relative to its peers in the Food Processing industry. The company's revenue concentration and geographic exposure are not disclosed in the available data, making it difficult to evaluate the risk associated with its business segments or regional dependencies. Growth trajectory is also unclear, as the outlook for the current and next fiscal year does not include numeric deltas or directional guidance for revenue or earnings. This lack of forward-looking data hinders the ability to model future performance. Risk factors include the inability to assess liquidity risk, which is a critical concern for any company's financial health. Additionally, the absence of detailed risk assessments and the lack of disclosed dilution sources make it challenging to evaluate the company's exposure to external pressures. Recent events, such as filings or transcripts, are not available in the provided data, which limits the ability to understand the company's strategic direction or operational developments.
Key takeaways
  • Pajson Agro India Ltd has no difference between basic and diluted shares outstanding, indicating no dilution from options or convertibles.
  • Liquidity risk could not be assessed due to missing balance-sheet data and no going-concern language in source documents.
  • Profitability and return metrics are not available for comparison against industry benchmarks.
  • Revenue concentration, geographic exposure, and growth trajectory are not disclosed in the available data.
  • Recent events and filings are not available, limiting insight into the company's strategic direction.
  • --
  • **RATIONALES**:
  • ```json
Financial snapshot
PeriodHA-latest
CurrencyINR
Revenue
Gross profit
Operating income
Net income
R&D
SG&A
D&A
SBC
Operating cash flow
CapEx
Free cash flow
Total assets
Total liabilities
Total equity
Cash & equivalents
Long-term debt
Annual history (last 5)
PeriodRevenueOp IncomeNet IncomeFCF
FY-4$154.6M-$5.7M-$5.7M-$200.6M
FY-3$1.01B$27.1M$167.0k$5.1M
FY-2$959.1M$46.4M$33.5M-$11.9M
FY-1$1.87B$289.0M$204.2M$134.3M
FY0$2.56B$347.1M$247.8M$144.2M
PeriodGross %Op %Net %FCF %
FY-4
FY-3
FY-2
FY-1
FY0
PeriodAssetsEquityCashDebt
FY-4$316.2M$204.3M$2.3M
FY-3$501.7M$204.4M$6.1M
FY-2$553.9M$237.9M$5.5M
FY-1$658.2M$442.1M$51.2M
FY0$1.96B$1.36B$551.0M
PeriodOCFCapExFCFSBC
FY-4-$115.2M-$197.3M-$200.6M
FY-3$116.4M-$4.5M$5.1M
FY-2-$89.5M-$55.1M-$11.9M
FY-1$161.3M-$83.7M$134.3M
FY0-$139.1M-$122.9M$144.2M
Quarterly history (last 4)
PeriodRevenueOp IncomeNet IncomeFCF
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodGross %Op %Net %FCF %
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodAssetsEquityCashDebt
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
PeriodOCFCapExFCFSBC
FQ-7
FQ-6
FQ-5
FQ-4
FQ-3
FQ-2
FQ-1
FQ0
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book
Net cash
Current ratio
Debt/Equity
ROA
ROE
Cash conversion
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskUnknown
  • Liquidity risk could not be assessed (no balance-sheet inputs and no going-concern language in source documents).
Industry benchmarks
Activity: Food Processing · cohort 1040 companies
MetricPAJSActivity
Op margin5.6% medp25 2.1% · p75 11.2%
Net margin3.9% medp25 0.5% · p75 8.5%
Gross margin23.3% medp25 14.8% · p75 32.6%
R&D / revenue0.8% medp25 0.5% · p75 2.3%
CapEx / revenue-4.1% medp25 -8.9% · p75 -1.9%
Debt / equity37.6% medp25 7.2% · p75 84.5%
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod FQ-7 · history via verified-market-data
no public URL
2026-05-13 00:17 UTC#849259ae
Source: analysis-pipeline (hybrid)Generated: 2026-05-28 21:57 UTCJob: 8b79bf71